Oral mucositis on a chip: modeling induction by chemo- and radiation treatments and recovery.

Biofabrication

Department of Biomedical Engineering, School of Engineering, Catholic University of America, Washington, DC 20064, United States of America.

Published: October 2022

AI Article Synopsis

  • Oral mucositis (OM) significantly impacts about 70% of head and neck cancer patients undergoing chemotherapy or radiation, and currently there is no effective preventative treatment.
  • A new study introduces a microfluidic chip model mimicking oral mucosa that combines keratinocytes with fibroblasts and endothelial cells, enhanced with a stable collagen gel to support long-term culture.
  • The model demonstrated the effects of chemotherapy (cisplatin) and radiation on oral mucosa, allowing researchers to observe the damage and recovery processes, paving the way for better understanding and treatment development for OM.

Article Abstract

Oral mucositis (OM) is a debilitating complication affecting roughly 70% of head and neck cancer patients receiving chemotherapy and/or radiation treatment. No broadly effective preventative treatment for OM exists. Therefore, anmodel of cancer treatment-induced OM would aid studies into possible origins of the pathology and future drug targets to ameliorate it. In this study, we present a microfluidic oral mucosa triculture tissue construct consisting of a keratinocyte layer attached to a subepithelial fibroblast and endothelial cell-embedded collagen gel. To address the typically low stability of mucosal constructs in microfluidics, ruthenium-catalyzed photocrosslinking was implemented to strengthen the collagen gel and prevent the invasion of keratinocytes, thus maintaining tissue construct geometry and oral mucosa barrier function for over 18 d of culture. Next, the OM chip was exposed to cisplatin (day 10) and damaging radiation (day 11, ± cisplatin at day 10), mimicking damage from cancer therapy. Damage to and then recovery of the tissue layers and function were observed over days 11-18. Therefore, several important features of OM induction and resolution were modeled in microfluidic culture. The OM model on a chip allows for more sophisticated studies into mechanisms of OM and potential treatments.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780701PMC
http://dx.doi.org/10.1088/1758-5090/ac933bDOI Listing

Publication Analysis

Top Keywords

oral mucositis
8
oral mucosa
8
tissue construct
8
collagen gel
8
cisplatin day
8
oral
4
mucositis chip
4
chip modeling
4
modeling induction
4
induction chemo-
4

Similar Publications

Introduction: Although tyrosine kinase inhibitors (TKIs) are effective against NSCLC harboring sensitizing gene mutations, acquired resistance is inevitable. Preclinical studies suggest that combining EGFR TKI and monoclonal antibody therapies may have activity in mutated NSCLC that has progressed on TKI therapy alone. Therefore, we prospectively evaluated afatinib plus necitumumab in patients with mutated NSCLC.

View Article and Find Full Text PDF

Background: Timolol is a beta-adrenergic blocker that has been shown to be effective in the healing of wounds. Oral mucositis (OM), an acute inflammation of the oral mucosa, is a bothersome side effect of some regimens of chemotherapy in which the oral mucosa becomes ulcerated. The current study aimed to evaluate the prophylactic effects of timolol mouthwash in preventing OM in adult patients receiving chemotherapy compared to the placebo.

View Article and Find Full Text PDF

Objectives: To evaluate the treatment of peri-implant mucositis (PM) using a nonsurgical submarginal peri-implant instrumentation (NSPI) with or without chlorhexidine (CHX) solutions.

Methods: Fifty-six patients (28 per group) were randomly assigned to the test (NSPI + 0.12% mouthwash and subgingival CHX irrigation plus tongue brushing with 1% CHX gel) or the control group (NSPI + placebo mouthwash and subgingival placebo irrigation plus tongue brushing with placebo gel).

View Article and Find Full Text PDF

State of knowledge of the relationship between celiac disease and oral pathology: A scoping review.

Med Oral Patol Oral Cir Bucal

January 2025

Oral Medicine, Department of Stomatology School of Dentistry, University of Granada Granada, Paseo de Cartuja s/n, 18071 Granada, Spain

Background: Celiac disease (CD) is a systemic disorder characterized by an enteropathy of highly variable clinical expression, in which the relationship with oral pathology has not yet been fully elucidated. We aimed to update the current knowledge on oral manifestations in CD, to identify evidence gaps and to point out future research lines.

Material And Methods: PRISMA-ScR guidelines were followed.

View Article and Find Full Text PDF

Background And Aims: Chemotherapy is one of the treatments of choice for patients with hematological or head and neck neoplasms. However, chemotherapy promotes elevate occurrence of adverse events and many of them directly impact nutritional status and patients' quality of life, which may include a low treatment tolerance. Suggested mechanisms include inflammation and oxidative stress as contributing factors to adverse effects of chemotherapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!